Feb 032016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– FRANCE, Lyon – ENYO Pharma, a biopharmaceutical company focused on developing treatments for acute and chronic viral infections, today announced that it has secured a €22 million Series A financing round. The investment is intended to help the company roll out its clinical hepatitis-B programme more quickly.… => more

ENYO Pharma adds Chahra Louafi to its Board along with closing €22m Series A funding round led by So finnova Partners

From:: ENYO Pharma adds Chahra Louafi to its Board along with closing €22m Series A funding round led by So finnova Partners

 Posted by at 2:54 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: